241 related articles for article (PubMed ID: 29383743)
1. Investigating the effect of key mutations on the conformational dynamics of toll-like receptor dimers through molecular dynamics simulations and protein structure networks.
Mahita J; Sowdhamini R
Proteins; 2018 Apr; 86(4):475-490. PubMed ID: 29383743
[TBL] [Abstract][Full Text] [Related]
2. Probing subtle conformational changes induced by phosphorylation and point mutations in the TIR domains of TLR2 and TLR3.
Mahita J; Sowdhamini R
Proteins; 2018 May; 86(5):524-535. PubMed ID: 29383749
[TBL] [Abstract][Full Text] [Related]
3. In silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2L.
Basith S; Manavalan B; Govindaraj RG; Choi S
PLoS One; 2011; 6(8):e23989. PubMed ID: 21897866
[TBL] [Abstract][Full Text] [Related]
4. Three conserved MyD88-recruiting TLR residues exert different effects on the human TLR4 signaling pathway.
Ding Y; Qiu Y; Zou L; Tan Z; Dai J; Xu W
Immunol Res; 2015 Jun; 62(2):213-21. PubMed ID: 25948473
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.
Gautam JK; Ashish ; Comeau LD; Krueger JK; Smith MF
J Biol Chem; 2006 Oct; 281(40):30132-42. PubMed ID: 16893894
[TBL] [Abstract][Full Text] [Related]
7. Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions.
Stack J; Bowie AG
J Biol Chem; 2012 Jun; 287(27):22672-82. PubMed ID: 22593572
[TBL] [Abstract][Full Text] [Related]
8. Insight into the sequence-structure relationship of TLR cytoplasm's Toll/Interleukin-1 receptor domain towards understanding the conserved functionality of TLR 2 heterodimer in mammals.
Ghosh SK; Saha B; Banerjee R
J Biomol Struct Dyn; 2021 Sep; 39(15):5348-5357. PubMed ID: 32643540
[TBL] [Abstract][Full Text] [Related]
9. Divergent roles of amino acid residues inside and outside the BB loop affect human Toll-like receptor (TLR)2/2, TLR2/1 and TLR2/6 responsiveness.
Qiu Y; Ding Y; Zou L; Tan Z; Liu T; Fu X; Xu W
PLoS One; 2013; 8(4):e61508. PubMed ID: 23626692
[TBL] [Abstract][Full Text] [Related]
10. Integrative modelling of TIR domain-containing adaptor molecule inducing interferon-β (TRIF) provides insights into its autoinhibited state.
Mahita J; Sowdhamini R
Biol Direct; 2017 Apr; 12(1):9. PubMed ID: 28427457
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.
Mistry P; Laird MH; Schwarz RS; Greene S; Dyson T; Snyder GA; Xiao TS; Chauhan J; Fletcher S; Toshchakov VY; MacKerell AD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5455-60. PubMed ID: 25870276
[TBL] [Abstract][Full Text] [Related]
12. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
13. A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer.
Patra MC; Batool M; Haseeb M; Choi S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325904
[TBL] [Abstract][Full Text] [Related]
14. Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome.
Halabi S; Sekine E; Verstak B; Gay NJ; Moncrieffe MC
J Biol Chem; 2017 Jan; 292(2):652-660. PubMed ID: 27909057
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
17. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.
Tao X; Xu Y; Zheng Y; Beg AA; Tong L
Biochem Biophys Res Commun; 2002 Nov; 299(2):216-21. PubMed ID: 12437972
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional implications of leucine-rich repeats in toll-like receptor1 subfamily.
Dey D; Dhar D; DAS S; Maulik A; Basu S
J Biosci; 2022; 47():. PubMed ID: 36222137
[TBL] [Abstract][Full Text] [Related]
19. Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.
Noreen M; Arshad M
Immunol Res; 2015 Jun; 62(2):234-52. PubMed ID: 25784622
[TBL] [Abstract][Full Text] [Related]
20. An alanine-to-proline mutation in the BB-loop of TLR3 Toll/IL-1R domain switches signalling adaptor specificity from TRIF to MyD88.
Verstak B; Arnot CJ; Gay NJ
J Immunol; 2013 Dec; 191(12):6101-9. PubMed ID: 24198284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
